ITRM
NSCIterum Therapeutics plc
Healthcare•Biotechnology
Watchlists:
Last updated: Wednesday 9th July 2025
0.93
+0.01 (1.01%)
Prev Close:0.9237
Open:0.932
Bid:0.92
Ask:0.93
52 Week Range
0.813.02
Volume:524,714
Mkt Cap:39 M
26
MarketXLS Rank ®
Weak Hold
Price Target
$1.07
+14.7%
Financials
Financial Statements
ITRM - Balance Sheet (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Invalid date | |
|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 251000.0 | 5 M | 3 M | 878000.0 | 816000.0 | 15 M | 4 M | |
| Accrued Interest Receivable | 55000.0 | 290000.0 | 7000.0 | 158000.0 | ||||
| Accumulated Depreciation & Depletion | -340000.0 | -315000.0 | -284000.0 | -391000.0 | -514000.0 | -353000.0 | -201000.0 | |
| Cash And Equivalents | 24 M | 6 M | 21 M | 27 M | 15 M | 5 M | 45 M | |
| Cash Cash Equivalents And Short Term Investments | 24 M | 24 M | 61 M | 81 M | 15 M | 5 M | 85 M | |
| Cash Equivalents | 30000.0 | 30000.0 | ||||||
| Common Stock | 315000.0 | 135000.0 | 126000.0 | 122000.0 | 494000.0 | 149000.0 | 144000.0 | |
| Current Accrued Expenses | 3 M | 8 M | 4 M | 1 M | 2 M | 12 M | 7 M | |
| Current Capital Lease Obligation | 67000.0 | 365000.0 | 332000.0 | 464000.0 | 573000.0 | 580000.0 | 904000.0 | |
| Float Term Debt | 20 M | 11 M | 10 M | 7 M | 22 M | 14 M | 15 M | |
| Goodwill And Other Intangible Assets | 20 M | 2 M | 3 M | |||||
| Income Tax Payable | 221000.0 | 102000.0 | 200000.0 | 113000.0 | ||||
| Line Of Credit | 15 M | |||||||
| Long Term Capital Lease Obligation | 68000.0 | 553000.0 | 2 M | 4 M | 6 M | 7 M | ||
| Long Term Debt And Capital Lease Obligation | 20 M | 11 M | 10 M | 7 M | 22 M | 8 M | 13 M | |
| Long Term Provisions | 18 M | 13 M | ||||||
| Non Current Deferred Taxes Assets | -45 M | -42 M | -37 M | -34 M | -31 M | 28 M | 14 M | |
| Other Current Liabilities | 11 M | 761000.0 | 2 M | 3 M | 4 M | 3 M | 2 M | |
| Payables | 251000.0 | 5 M | 3 M | 1 M | 918000.0 | 16 M | 4 M | |
| Retained Earnings | -486 M | -461 M | -423 M | -378 M | -287 M | -235 M | -132 M | |
| Taxes Receivable | 48000.0 | 38000.0 | 302000.0 | 75000.0 | 64000.0 | 68000.0 | 159000.0 | |
| Total Capitalization | 47 M | 17 M | 48 M | 64 M | -6 M | -5 M | 100 M | |
| Total Equity Gross Minority | -4 M | -6 M | 28 M | 50 M | -51 M | -26 M | 72 M | |
| Total Equity Gross Minority Interest | -4 M | -6 M | 28 M | 50 M | -51 M | -26 M | 72 M | |
| Total Liabilities And Total Equity Gross Minority Interest | 45 M | 26 M | 67 M | 92 M | 33 M | 26 M | 98 M | |
| Total Non Current Liabilities Net Minority Interes | 20 M | 19 M | 30 M | 28 M | 42 M | 15 M | 14 M | |
| Total Tax Payable | 221000.0 | 102000.0 | 200000.0 | 113000.0 | ||||
| Working Capital | 7 M | 12 M | 53 M | 70 M | -20 M | -25 M | 81 M | |
| Addpaid | 482 M | 455 M | 451 M | 429 M | 236 M | 209 M | 203 M | |
| Capstk | 315000.0 | 135000.0 | 126000.0 | 122000.0 | 494000.0 | 149000.0 | 144000.0 | |
| Comstkeqty | -4 M | -6 M | 28 M | 50 M | -51 M | -26 M | 72 M | |
| Curdebt | 14 M | 2 M | 6 M | 6 M | 1 M | |||
| Curdebtcaplease | 14 M | 2 M | 6 M | 6 M | 1 M | |||
| Grosppe | 363000.0 | 366000.0 | 353000.0 | 482000.0 | 935000.0 | 925000.0 | 901000.0 | |
| Netppe | 23000.0 | 51000.0 | 69000.0 | 91000.0 | 421000.0 | 572000.0 | 700000.0 | |
| Noncurdefliab | 24000.0 | 49000.0 | ||||||
| Othca | 2 M | 2 M | 3 M | 3 M | 3 M | 2 M | 428000.0 | |
| Othintang | 20 M | -5 M | 2 M | 3 M | ||||
| Othnca | 39000.0 | 612000.0 | 3 M | 5 M | 11 M | 13 M | 4 M | |
| Othncl | 8 M | 20 M | 3 M | 6 M | 7 M | 951000.0 | ||
| Othprop | 23000.0 | 51000.0 | 69000.0 | 91000.0 | 421000.0 | 572000.0 | 700000.0 | |
| Othrec | 37000.0 | |||||||
| Payacc | 3 M | 13 M | 7 M | 2 M | 3 M | 28 M | 11 M | |
| Prepaid | 614000.0 | 2 M | 1 M | 2 M | 7 M | 7 M | 8 M | |
| Restcash | 60000.0 | |||||||
| Totassets | 45 M | 26 M | 67 M | 92 M | 33 M | 26 M | 98 M | |
| Totca | 25 M | 26 M | 62 M | 83 M | 21 M | 12 M | 93 M | |
| Totcl | 18 M | 14 M | 9 M | 13 M | 42 M | 37 M | 12 M | |
| Toteqty | -4 M | -6 M | 28 M | 50 M | -51 M | -26 M | 72 M | |
| Totliab | 49 M | 33 M | 39 M | 41 M | 83 M | 52 M | 26 M | |
| Totnca | 20 M | 663000.0 | 4 M | 8 M | 11 M | 14 M | 5 M | |
| Totncl | 20 M | 19 M | 30 M | 28 M | 42 M | 15 M | 14 M |
Call: 1-877-778-8358 
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.
I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...
MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.
I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.